Nutritional Psychiatry: From Concept to the Clinic.


Journal

Drugs
ISSN: 1179-1950
Titre abrégé: Drugs
Pays: New Zealand
ID NLM: 7600076

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 23 5 2019
medline: 18 12 2019
entrez: 23 5 2019
Statut: ppublish

Résumé

The field of 'nutritional psychiatry' has evolved with rapidity over the past several years, with an increasing amount of dietary or nutrient-based (nutraceutical) intervention studies being initiated, and more preclinical and epidemiological data being available. This emergent paradigm involves the clinical consideration (where appropriate) of prescriptive dietary modification/improvement, and/or the select judicious use of nutrient-based supplementation to prevent or manage psychiatric disorders. In the last several years, significant links have increasingly been established between dietary quality and mental health (although not all data are supportive). Maternal and early-life nutrition may also affect the mental health outcomes in offspring. In respect to nutraceutical research, like with many recent conventional drug studies, results are fairly mixed across the board, and in many cases there is not emphatic evidence to support the use of nutraceuticals in various psychiatric disorders. This may in part be due to a preponderance of recent studies within the field revealing marked placebo effects. Due to current indicators pointing towards mental disorders having an increasing burden of disease, bold and innovative approaches on a societal level are now required. In light of the widespread use of nutrient supplements by those with and without mental disorders, it is also critical that scientifically rigorous methodologies be brought to bear on the assessment of the efficacy of these supplements, and to determine if, or what dose of, a nutrient supplement is required, for whom, and when, and under what circumstances. More simple studies of additional isolated nutrients are not of great benefit to the field (unless studied in supra-dosage in an individualised, biomarker-guided manner), nor, based on recent data, is the research of 'shotgun' formulations of nutraceuticals. The next critical step for the field is to design psychiatric interventional studies for both dietary modification and nutraceuticals, based on more of a personalised medicine approach, using biomarkers (e.g. nutrient deficiencies, inflammatory cytokine levels, genomic assessment, microbiome analysis) and a person's dietary patterns and individual macro/micronutrient requirements.

Identifiants

pubmed: 31114975
doi: 10.1007/s40265-019-01134-9
pii: 10.1007/s40265-019-01134-9
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

929-934

Références

Dis Nerv Syst. 1951 Apr;12(4):105-9
pubmed: 14822792
Nutr Rev. 1951 Oct;9(10):314-5
pubmed: 14882689
Lancet. 2007 Sep 8;370(9590):859-77
pubmed: 17804063
Explore (NY). 2012 Jan-Feb;8(1):50-7
pubmed: 22225934
Expert Rev Neurother. 2013 Jan;13(1):49-73
pubmed: 23253391
Clin Nutr. 2014 Feb;33(1):115-21
pubmed: 23541912
BMC Psychiatry. 2013 Jun 27;13:175
pubmed: 23802679
Biol Psychiatry. 2013 Dec 15;74(12):872-8
pubmed: 23806573
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
J Am Acad Child Adolesc Psychiatry. 2013 Oct;52(10):1038-47
pubmed: 24074470
BMC Med. 2013 Sep 20;11:208
pubmed: 24229349
J Physiol Anthropol. 2014 Jan 15;33:2
pubmed: 24422720
BMC Psychiatry. 2014 Apr 10;14:107
pubmed: 24721040
CNS Drugs. 2014 Sep;28(9):775-85
pubmed: 25056569
J Physiol Anthropol. 2014 Jul 24;33:22
pubmed: 25060574
Am J Public Health. 2014 Oct;104(10):e31-42
pubmed: 25208008
Mol Psychiatry. 2016 Jan;21(1):71-9
pubmed: 25802980
Lancet Psychiatry. 2015 Mar;2(3):246-57
pubmed: 25815249
Neurosci Biobehav Rev. 2015 Aug;55:294-321
pubmed: 25957927
Lancet Psychiatry. 2015 Mar;2(3):271-4
pubmed: 26359904
World Psychiatry. 2015 Oct;14(3):370-1
pubmed: 26407799
Circulation. 2016 Jan 12;133(2):187-225
pubmed: 26746178
Am J Psychiatry. 2016 Jun 1;173(6):575-87
pubmed: 27113121
Psychol Med. 2016 Aug;46(11):2287-97
pubmed: 27193198
BMC Med. 2017 Jan 30;15(1):23
pubmed: 28137247
EBioMedicine. 2017 Mar;17:24-29
pubmed: 28242200
Proc Nutr Soc. 2017 Nov;76(4):427-436
pubmed: 28942748
J Affect Disord. 2018 Jan 15;226:346-354
pubmed: 29031185
J Psychosom Res. 2018 May;108:85-92
pubmed: 29602330
Eur Neuropsychopharmacol. 2018 Oct;28(10):1126-1136
pubmed: 30115553
World Psychiatry. 2018 Oct;17(3):365-367
pubmed: 30192082
Mol Psychiatry. 2019 Jul;24(7):965-986
pubmed: 30254236
Clin Nutr. 2018 Nov 20;:null
pubmed: 30502975
BMC Med. 2018 Dec 28;16(1):236
pubmed: 30591046
BMC Med. 2018 Dec 28;16(1):243
pubmed: 30591065
BMC Med. 2019 Jan 25;17(1):18
pubmed: 30678686
J Affect Disord. 2019 Feb 15;245:1007-1015
pubmed: 30699842
Psychosom Med. 2019 Apr;81(3):265-280
pubmed: 30720698
JAMA. 2019 Mar 5;321(9):842-843
pubmed: 30835294
JAMA. 2019 Mar 5;321(9):858-868
pubmed: 30835307
Br J Psychiatry. 1995 May;166(5):601-6
pubmed: 7620744

Auteurs

Jerome Sarris (J)

NICM Health Research Institute, Western Sydney University, 158 Hawkesbury Rd, Westmead, NSW, 2145, Australia. j.sarris@westernsydney.edu.au.
Professorial Unit, The Melbourne Clinic, Department of Psychiatry, Melbourne University, Richmond, VIC, Australia. j.sarris@westernsydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH